#United States #Class Action #Securities Fraud #Radnor #Geron Corporation

Kessler Topaz Meltzer & Check, LLP Investments Update

In recent news, the law firm Kessler Topaz Meltzer & Check, LLP has informed investors regarding ongoing securities class action lawsuits against Geron Corporation (NASDAQ: GERN). This notification outlines critical information relevant to individuals who purchased or acquired Geron securities between February 28, 2024, and February 25, 2025, a period identified as the 'Class Period.' Investors are particularly drawn to the implications of the lawsuit amid allegations of misleading statements from Geron's defendants regarding the operational performance and expected revenues from its primary product.

Allegations and Misconduct

The complaints indicate that Geron’s management allegedly provided investors with optimistic, yet misleading information regarding its financial outlook and product performance. Specifically, the documents claim that the defendants falsely portrayed their confidence in Geron's revenue potential, primarily stemming from the launch of its drug RYTELO. Reports of the drug's expected success were said to undermine the realities posed by competition, seasonal market fluctuations, and other economic factors. Consequently, investors felt misled by the company's portrayal of its operational success and market readiness.

Among the main allegations are that:
1. False Optimism: Defendants created a misleading impression that Geron was positioned for success despite the actual market challenges.
2. Exaggerated Launch Success: Public announcements regarding RYTELO's launch success were allegedly inflated to minimize perceived risks, leaving investors with an inaccurate sense of product viability against competitors.
3. Market Penetration Issues: RYTELO's awareness and market infiltration were purportedly overstated, which constrained Geron’s ability to address the considerable demand purportedly represented by first-line patients and non-academic settings.
4. Overall Misrepresentation: The statements made regarding Geron’s business operations, product prospects, and growth potential were said to be misleading or devoid of a reasonable basis.

Lead Plaintiff Process

Investors impacted by Geron’s alleged misconduct are urged to act promptly as the deadline to apply as a lead plaintiff is set for May 12, 2025. Potential lead plaintiffs must have a substantial financial stake in the lawsuit and should be able to represent the interests of all class members adequately.

Being a lead plaintiff comes with significant responsibilities as such individuals will play a crucial role in directing the proceedings against Geron and selecting an attorney to represent the class. However, it’s important to note that opting to remain an absent class member still allows for participation in any recovery from the lawsuit. Kessler Topaz Meltzer & Check, LLP encourages investors to evaluate their options thoroughly to ensure they maximize their potential recovery.

Contact Information

For those who believe they have suffered financial losses due to Geron's alleged deceptive practices, Kessler Topaz Meltzer & Check, LLP advises contacting them directly for more information. Inquiries can be made via phone at (484) 270-1453 or through email at [email protected]

Through its commitment to advocating for investors, Kessler Topaz Meltzer & Check, LLP emphasizes the importance of safeguarding shareholder rights in the face of corporate misconduct. Potential claimants can also visit their website for further details about the ongoing litigation against Geron Corporation.

Ongoing Commitment to Investor Protection

Kessler Topaz Meltzer & Check, LLP has cultivated a strong reputation for its effectiveness in prosecuting class actions and recovering billions for victims of corporate fraud. The firm remains dedicated to protecting the interests of investors, workers, and consumers against abuses and mismanagement. For further inquiries about Kessler Topaz Meltzer & Check, LLP, or to learn about their legal services, please visit www.ktmc.com.